JAMA internal medicine
JAMA internal medicine
Audio Summaries
Every issue of JAMA internal medicine moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
JAMA internal medicine covers research in these specialties.
Recent summaries
The latest articles summarized from JAMA internal medicine.
Removing Race From Standardized Mortality Ratio Risk Adjustment in Dialysis Care Quality Measurement.
Nov 16, 2026
This cross-sectional study of 6,895 US dialysis facilities asks how removing race and ethnicity from CMS standardized mortality ratio (SMR) risk adjustment changes facility-level mortality performance, especially for facilities serving socially disadvantaged populations. Without race adjustment, the SMR gap between low- and high-social-risk facilities (0.10) was nearly eliminated, and about 21.6% of high-social-risk facilities improved their rankings versus 1.9% of low-risk facilities. The largest gains occurred among facilities serving the highest proportions of non-Hispanic Black patients, suggesting that removing race from risk adjustment would shift public performance comparisons in favor of facilities serving populations with greater social risk.
Reducing Low-Value Care Through the Smarter Care Virginia Initiative.
Nov 9, 2026
This quality improvement study asked whether a clinician-led, statewide initiative in Virginia (Smarter Care Virginia) could reduce low-value care across 18 health systems. Using a difference-in-differences design comparing 6 intervention systems with 12 control systems from 2019 to 2022, the authors found a small but statistically significant drop in patients receiving at least one of nine low-value services (from 10.5% to 8.5% in the intervention group, an absolute reduction of 1.1 percentage points) with no increase in adverse events or change in spending. The authors conclude that larger reductions will likely require payment reform and accountability measures alongside health system-driven efforts.
Drug Burden Index Stewardship to Deprescribe Anticholinergic or Sedative Drugs in Older Inpatients: A Stepped-Wedge Cluster Randomized Clinical Trial.
Nov 9, 2026
This stepped-wedge cluster randomized trial across 6 Australian public hospitals asked whether an intervention bundle (automated Drug Burden Index scores in the EMR, deprescribing guides, and, in the intervention phase, stewardship pharmacist recommendations) would increase deprescribing of anticholinergic and sedative medications in 4,827 older inpatients. The intervention produced a modest, smaller-than-hypothesized increase in the proportion of patients with at least one DBI-contributing medication deprescribed at discharge (41.4% vs 38.1% in control; adjusted difference 5.3 percentage points), and the gain was not sustained after the stewardship component ended. Deprescribing recommendations in discharge summaries rose during the intervention phase, with no difference in in-hospital adverse events across phases.
Risk of Shoulder Injury Related to Vaccine Administration for COVID-19 and Influenza Vaccinations.
Nov 4, 2026
This population-based cohort study of adults at Kaiser Permanente Southern California asked whether shoulder injury related to vaccine administration (SIRVA) occurs more often after COVID-19 vaccination than after influenza vaccination. Among 1.83 million vaccinations, SIRVA incidence was 1.84 per 10,000 for COVID-19 versus 1.15 per 10,000 for influenza, an adjusted risk ratio of 1.63 (about 7 additional cases per 100,000 vaccinations). Among adults 65 and older, the difference compared with high-dose influenza vaccine was not statistically significant, and the authors note the absolute risk remains small relative to vaccine benefits.
Surveillance Mammography and Second Primary Breast Cancer Diagnosis Among Older Women With a History of Breast Cancer.
Nov 2, 2026
This retrospective cohort study of about 9,900 women aged 67 and older with nonmetastatic breast cancer used SEER-Medicare data to ask whether continued surveillance mammography after 5 years reduces the risk of advanced second primary breast cancer. Continued surveillance was not associated with a lower risk of advanced second cancer (1.65% vs 2.15% cumulative incidence; HR 0.76, 95% CI 0.46-1.26), and results were similar for hormone receptor-positive and -negative subgroups. The authors conclude that because advanced cancer risk was low, surveillance decisions should be individualized, weighing potential burdens of continued screening.
Preoperative Medicine for the Internal Medicine Clinician: A Review.
Oct 26, 2026
This review addresses how internal medicine clinicians, who frequently perform preoperative evaluations but receive limited perioperative training, can contribute to safer and higher-value surgical care. The authors outline a stepwise, evidence-informed approach that combines history, physical examination, test interpretation, and guideline-based risk reduction, with attention to undifferentiated symptoms and shared decision-making. They conclude that a structured preoperative assessment can improve patient preparation and inform surgical and anesthesiology management during and after surgery.
Preoperative Intranasal Oxytocin and Probable Acute Stress Disorder After Traumatic Fracture Surgery: A Randomized Clinical Trial.
Oct 26, 2026
This randomized, double-blind, placebo-controlled trial asked whether a single preoperative dose of intranasal oxytocin (40 IU) could prevent probable acute stress disorder (ASD) in 328 adults undergoing traumatic fracture surgery. Within 3 days after surgery, screening-positive probable ASD occurred in 15.9% of the oxytocin group versus 30.5% of the saline group (risk ratio 0.52), with no serious adverse events reported. The findings suggest intranasal oxytocin may be a feasible perioperative preventive strategy, though the mechanistic and long-term safety conclusions remain exploratory.
Video Decision Support and Advance Care Planning in Older Adults With Advanced Kidney Disease: The VIDEO-KD Randomized Clinical Trial.
Oct 23, 2026
This randomized clinical trial asked whether a video decision aid about dialysis, hemodialysis, peritoneal dialysis, and conservative kidney management, paired with patient-created video declarations of goals and preferences, would increase advance care planning documentation among adults aged 65 and older with advanced CKD. Across 453 patients at 12 ambulatory clinics, ACP documentation at 12 months was higher in the intervention group than in controls (56.6% vs 40.0%, rate difference 16.6%), and fewer intervention participants were undecided about treatment after viewing the video. The findings suggest that a video decision aid combined with patient video declarations can meaningfully improve ACP documentation and decisional clarity in this population.
Cost-Effectiveness of HCV Screening in Emergency Departments Using DETECT Hep C Trial Results.
Oct 19, 2026
This economic evaluation asks whether HCV screening in U.S. emergency departments is cost-effective, comparing no ED screening, targeted screening, and nontargeted (routine) screening using a simulation model informed by the DETECT Hep C trial. Nontargeted screening yielded the most infections cured (65.89%) at an ICER of about $12,820 per QALY gained, well below the $100,000/QALY threshold, with costs similar across strategies. The authors conclude that routine nontargeted HCV screening in EDs offers good economic value and could support HCV elimination efforts.
Mifepristone Patient Agreement Form and Medication Abortion Knowledge: A Randomized Clinical Trial.
Oct 19, 2026
This randomized clinical trial asked whether reviewing and signing the FDA-required patient agreement form (PAF) for mifepristone improves patients' medication abortion knowledge. Among 593 patients across five U.S. facilities, those who received the PAF scored nearly identically to controls on a 12-item knowledge survey (adjusted difference 0.18 items, 95% CI -0.04 to 0.39), and overall knowledge was already high after standard counseling. The authors conclude that the PAF did not produce a clinically meaningful knowledge gain, raising questions about its usefulness.
